Randomized Controlled Trial of Treatment to Optimize Heart Rate Variability for Persistent Post-Concussion Symptoms
Key facts
- Who runs it
- Virginia Commonwealth University
- Where
- Richmond, United StatesSee the site
- Trial code
- Status
- Recruiting
- Phase
- Phase 2/3
- People taking part
- 148 people, planned
- Started
- 2 Sept 2025
- Expected to end
- Sept 2028
- Type of study
- Interventional, 2 groups
- Treatments tested
- HRV Coherence Ratio
- NSI
- Pittsburgh Sleep Quality Index (PSQI)
- Quantitative Sleep Measures
- Patient Global Impression of Change (PGIC)
- Cognitive Performance/NIH Toolbox Cognitive Battery
- Pain Interference/TBI-QoL Pain Interference Short-Form
- Patient Health Questionnaire-9 (PHQ-9)
- PTSD Checklist for DSM-5 (PCL-5)
- HRV Biofeedback (HRV-B)
- Psychoeducational (Edu) Comparator Intervention
- Record updated
- 22 September 2026
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 12 criteriaShow less
Who can take part
- age 18 or older
- History of military service
- Self-Reported hx of 1 or more mild TBI
- Most recent TBI more than 1 year ago
- Significant Persistent Post-Concussion Symptom burden (Neurobehavioral Symptom Inventory [NSI] total score greater than or equal to 20)
- Current Sleep Difficulties
- Fluent English
- Able to provide Informed Consent
Who cannot take part
- Any TBI with severity greater than mild (i.e., Moderate or Severe TBI defined as initial injury loss of consciousness (LOC) duration >30 minutes, posttraumatic amnesia (PTA) duration >24 hours, or traumatic hemorrhage on head computerized tomography (CT) and determined by the study investigator based on information gathered during administration of the study's validated TBI structured interview instrument
- Conditions or medications that can affect HRV measurement (pacemaker or an implant that stimulates your heart (e.g., cardioverter-defibrillator or ICD); heart transplant or heart surgery within the last year, including bypass or other surgery, but not including a stent)
- Hx of stroke
- Mental conditions that may impede adherence (e.g., dementia, psychotic disorder, panic disorder)
Where in United States
- Virginia Commonwealth UniversityRichmond, United StatesContact: Bret BrooksTaking people
About the trial
What the trial wants to find out
Many combat veterans (c-Vs), service members (SMs) and civilians with mild traumatic brain injury (mTBI, also termed concussion) suffer from persistent post-concussion symptoms (PPCS) that degrade physical and cognitive well-being and have been linked with early neurodegeneration. PPCS include somatosensory (e.g., headache, disturbed vision), vestibular (e.g., dizzy, clumsy), cognitive (e.g., executive function, memory) and affective symptoms (e.g., sleep disturbance, irritability, depression). A key pathological process that provokes and perpetuates PPCS is autonomic nervous system (ANS) dysfunction such as unremitting sympathetic nervous system activation that also exacerbates other pathology such as inflammation. ANS activity can be readily quantified by measuring heart rate variability (HRV), or the variation in heart rate over time, which serves as a valid index of both physiological and psychological health
The 2 groups in the trial
- Heart rate variability biofeedback (HRV-B)Treatment being tested
Behavioral intervention using HRV biofeedback (HRV-B) to treat Persistent Post-Concussion Symptoms (PPCS) among adults, including Combat Veterans (c-Vs) and Service Members (SMs), with history of single or repeated mTBI from blast-related or other mechanism.
Treatment: HRV Coherence Ratio, NSI, Pittsburgh Sleep Quality Index (PSQI), Quantitative Sleep Measures, Patient Global Impression of Change (PGIC), Cognitive Performance/NIH Toolbox Cognitive Battery, Pain Interference/TBI-QoL Pain Interference Short-Form, Patient Health Questionnaire-9 (PHQ-9), PTSD Checklist for DSM-5 (PCL-5), and HRV Biofeedback (HRV-B)
- EducationTreatment being tested
Psychoeducational treatment
Treatment: HRV Coherence Ratio, NSI, Pittsburgh Sleep Quality Index (PSQI), Quantitative Sleep Measures, Patient Global Impression of Change (PGIC), Cognitive Performance/NIH Toolbox Cognitive Battery, Pain Interference/TBI-QoL Pain Interference Short-Form, Patient Health Questionnaire-9 (PHQ-9), PTSD Checklist for DSM-5 (PCL-5), and Psychoeducational (Edu) Comparator Intervention
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Record updated
- 22 September 2026